Fragile X Mental Retardation, Autosomal Homolog 2 (FXR2) Peptide
-
- Target See all FXR2 products
- FXR2 (Fragile X Mental Retardation, Autosomal Homolog 2 (FXR2))
- Origin
- Human, Monkey, Mouse, Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Characteristics
- The peptide is used to block Anti-FXR2 Antibody reactivity.
-
-
- Application Notes
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Storage
- -20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year.
- Expiry Date
- 12 months
-
- Target
- FXR2 (Fragile X Mental Retardation, Autosomal Homolog 2 (FXR2))
- Synonyms
- id:ibd5046 Peptide, zgc:56215 Peptide, zgc:77472 Peptide, FMR1L2 Peptide, FXR2P Peptide, Fxr2h Peptide, FMR1 autosomal homolog 2 Peptide, fragile X mental retardation, autosomal homolog 2 Peptide, FXR2 Peptide, fxr2 Peptide, Fxr2 Peptide
- Background
- FMR1L2, Fragile X mental retardation syndrome-related protein 2
- Gene ID
- 9513
- UniProt
- P51116, Q9WVR4
-